Thousands of Patients from Scotland’s Poorest Areas to Benefit from Landmark UK Taxpayer-Funded Obesity Study
Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines Thousands of Patients from Scotland’s Poorest Areas to Benefit from Landmark UK Taxpayer-Funded Obesity Study Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines. University of Glasgow, pharmaceutical firm Novo Nordisk and IQVIA, a leading global provider of clinical research services, selected to plan and deliver the research involving 3,000 to 5,000 people...
What do you think?
Log in to reply to this SHMOOZ post.
There are no replies yet.